James T Kent Homoeo Lab Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.99 M
- Company Age 27 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.31 M
- Revenue Growth 15.29%
- Profit Growth -63.73%
- Ebitda 65.83%
- Net Worth 2.70%
- Total Assets 6.02%
About James T Kent Homoeo Lab
James T Kent Homoeo Lab Private Limited (JTKHLPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 December 1997 and has a history of 27 years and two months. Its registered office is in Kolkata, West Bengal, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.99 M.
The company currently has active open charges totaling ₹2.31 M.
Sarmistha Roy and Tanuja Dutta serve as directors at the Company.
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85193WB1997PTC086163
- Company No.
086163
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Dec 1997
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at James T Kent Homoeo Lab?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sarmistha Roy  | Director | 16-Mar-2002 | Current |
| Tanuja Dutta | Director | 01-Dec-2011 | Current |
Financial Performance of James T Kent Homoeo Lab.
James T Kent Homoeo Lab Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 15.29% increase. The company also saw a substantial fall in profitability, with a 63.73% decrease in profit. The company's net worth moved up by a moderate rise of 2.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of James T Kent Homoeo Lab?
In 2017, James T Kent Homoeo Lab had a promoter holding of 74.24% and a public holding of 25.76%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹2.31 M
₹0
Charges Breakdown by Lending Institutions
- Indian Bank : 0.23 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Nov 2020 | Indian Bank | ₹2.31 M | Open |
How Many Employees Work at James T Kent Homoeo Lab?
James T Kent Homoeo Lab has a workforce of 21 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of James T Kent Homoeo Lab, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped James T Kent Homoeo Lab's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
